Paul J. Lytle
Overview
Paul J. Lytle received an average of $603K in total compensation, including $317K in salary, at Peregrine Pharmaceuticals from 2007 to 2019.
2019Peregrine PharmaceuticalsFormer Chief Financial Officer
2018Peregrine PharmaceuticalsChief Financial Officer
2017Peregrine PharmaceuticalsChief Financial Officer
2016Peregrine PharmaceuticalsChief Financial Officer
2014Peregrine PharmaceuticalsChief Financial Officer
2013Peregrine PharmaceuticalsChief Financial Officer
2012Peregrine PharmaceuticalsChief Financial Officer
2007Peregrine PharmaceuticalsChief Financial Officer and Corporate Secretary
Source: SEC filings on August 21, 2019, August 17, 2018, August 28, 2014, and August 28, 2007.
Related executives
We found 13 more executives who work or worked at Peregrine Pharmaceuticals.
Nicholas Green
Peregrine Pharmaceuticals
Chief Executive Officer
Daniel Hart
Peregrine Pharmaceuticals
Chief Financial Officer
Mark Ziebell
Peregrine Pharmaceuticals
General Counsel
Matthew Kwietniak
Peregrine Pharmaceuticals
Chief Commercial Officer
Richard Richieri
Peregrine Pharmaceuticals
Chief Operations Officer
Richard Hancock
Peregrine Pharmaceuticals
Chief Executive Officer
Roger Lias
Peregrine Pharmaceuticals
Chief Executive Officer
Stephen Hedberg
Peregrine Pharmaceuticals